Sera Prognostics, Inc. (SERA) Sera Prognostics, Inc., a women’s health diagnostic company, discovers, develops, and commercializes biomarker tests for improving pregnancy outcomes in the United States. Spotify Technology S.A. (SPOT) Spotify Technology S.A., together with its subsidiaries, provides audio streaming subscription services worldwide. It operates through two segments, Premium and Ad-Supported. Kodiak Sciences Inc. (KOD) […]
Read MoreSera Prognostics, Inc., a women’s health diagnostic company, discovers, develops, and commercializes biomarker tests for improving pregnancy outcomes. The company develops PreTRM test, a blood-based biomarker test to predict the risk of spontaneous preterm birth in singleton pregnancies. It is also developing a portfolio of product candidates for various pregnancy-related conditions, including preterm birth, preeclampsia, […]
Read MoreCardiff Oncology Inc. (CRDF) is a clinical-stage biotechnology company focused on developing novel treatments for cancer. The company’s primary objective is to leverage its expertise in oncology and drug development to create therapies that can address unmet medical needs and improve the lives of patients battling cancer. Three main drivers of growth for Cardiff Oncology […]
Read MoreMicroStrategy Inc. (MSTR) is a global leader in enterprise analytics and mobility software. The company provides software solutions and expert services that empower organizations to make informed decisions based on data-driven insights. MicroStrategy’s analytics platform delivers high-performance business intelligence, including data mining, predictive analytics, and interactive dashboards, to help companies analyze trends, patterns, and relationships […]
Read More